Vimarsana
Biggest News Aggregation in the World

Page 46 - Practice Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Practice Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Practice Management Today - Breaking & Trending Today

3rd Circuit judicial nominee opposed for ties to group said to amplify 'antisemitic speech' and 'terrorist propaganda' - Vimarsana News

3rd Circuit judicial nominee opposed for ties to group said to amplify 'antisemitic speech' and 'terrorist propaganda'

The nomination of a BigLaw partner to serve on the 3rd U.S. Circuit Court of Appeals at Philadelphia should be withdrawn because of his service as a board member for a group with “a deep history of amplifying antisemitic speech, terrorist propaganda and anti-American rhetoric,” according to a letter to President Joe Biden by a group of Republican members of the U.S. House of Representatives.

Ex-NRA CEO didn't consult GCs office about key legal decisions, general counsel testifies - Vimarsana News

Ex-NRA CEO didn't consult GCs office about key legal decisions, general counsel testifies

Updated: Former National Rifle Association CEO Wayne LaPierre didn’t consult his general counsel before the group sued its advertising agency and sought bankruptcy protection, two legal filings that didn’t end well for the NRA, according to testimony Tuesday.

After sanctions threat, Trump lawyer in $83.3M defamation case drops conflict claim stemming from BigLaw overlap - Vimarsana News

After sanctions threat, Trump lawyer in $83.3M defamation case drops conflict claim stemming from BigLaw overlap

A lawyer for former President Donald Trump is backing away from a claim that an opposing lawyer and the judge in a defamation case involving writer E. Jean Carroll had an undisclosed conflict of interest.

Biogen Drops Alzheimer's Drug Aduhelm, Ending a 17-year Chapter - Vimarsana News

Biogen Drops Alzheimer's Drug Aduhelm, Ending a 17-year Chapter

Biogen will end a post-approval study of Alzheimer's treatment Aduhelm and return the licensing rights on the drug after failing to find a partner to mitigate costs of...

Short Interest in Dye & Durham Limited (OTCMKTS:DYNDF) Grows By 12.7% - Vimarsana News

Short Interest in Dye & Durham Limited (OTCMKTS:DYNDF) Grows By 12.7%

Dye & Durham Limited (OTCMKTS:DYNDF – Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,023,400 shares, an increase of 12.7% from the December 31st total of 908,300 shares. Based on an average daily volume of 8,300 shares, the days-to-cover […]